Endpoints for homocysteine-lowering trials (Q60154839)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682995%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Endpoints for homocysteine-lowering trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682995%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682995%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

A G Bostom

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682995%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682995%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682995%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682995%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

9203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682995%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

511-512

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682995%20AND%20SRC:MED&resulttype=core&format=json

Preventing Coronary Heart Disease

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900437-7

7 January 2021

Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900437-7

7 January 2021

Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900437-7

7 January 2021

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900437-7

7 January 2021

Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900437-7

7 January 2021

Lessons learned from studies of the standard exercise ECG test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900437-7

7 January 2021

Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900437-7

7 January 2021

Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900437-7

7 January 2021

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2899%2900437-7

7 January 2021

10.1016/S0140-6736(99)00437-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682995%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference